According to the Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation, patients with heart failure are classified into: heart failure with reduced ejection fraction (HFrEF, LVEF ...

The arterial vasculature is the second most frequently calcified structure in the human body after the skeleton. Calcification of the aorta and aortic valves occurs in most individuals in westernized ...

Severe hypothyroidism is associated with a high burden of systolic/diastolic ventricular dysfunction and myocardial deformation abnormalities.

A new study published in the journal of Frontiers in Cardiovascular Medicine revealed that Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) were associated with improved left ...

Dr. Burkhoff will summarize the robust body of pilot study clinical evidence demonstrating sustained and reproducible systolic blood pressure reductions associated with delivery of AVIM Therapy, along ...

The clinical results were presented by Dr. Amish Raval, M.D., Professor of Medicine at University of Wisconsin School of Medicine and Public Health and CardiAMP HF Trial National Co-Principal ...

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally ...

Researchers from the laboratory of Dr. Sufansa Sawamiphak, head of the group for the study of cardiovascular-hematopoietic ...

A modest modification of daily dietary habits resulted in a visible change within the human body in only two months. Research conducted by the Illinois Institute of Technology showed that adults who ...

Researchers discover a gut-brain-heart axis where the bacterial metabolite IAA regulates hypocretin neurons to control heart stiffness and blood pressure.

Hypertension and heart failure affect millions worldwide. Yet in many patients, doctors cannot fully explain why the heart ...

Pirfenidone is associated with fewer arrhythmic events and reduced diastolic dysfunction in patients with idiopathic pulmonary fibrosis.